Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Minimally invasive glaucoma surgery: Comparison of iStent with iStent inject in primary open angle glaucoma.

Hooshmand J, Rothschild P, Allen P, Kerr NM, Vote BJ, Toh T.

Clin Exp Ophthalmol. 2019 Sep;47(7):898-903. doi: 10.1111/ceo.13526. Epub 2019 May 16.

PMID:
31034687
2.

Bleb-associated endophthalmitis: Proportion, presentation, management and outcomes in Victoria, Australia.

Kwon HJ, Kumar H, Green CM, Crowston JG, McGuinness MB, Kerr NM.

Clin Exp Ophthalmol. 2019 Jul;47(5):588-597. doi: 10.1111/ceo.13477. Epub 2019 Mar 12.

PMID:
30788894
3.

The Safety and Efficacy of Supraciliary Stenting Following Failed Glaucoma Surgery.

Kerr NM, Wang J, Perucho L, Barton K.

Am J Ophthalmol. 2018 Jun;190:191-196. doi: 10.1016/j.ajo.2018.03.043. Epub 2018 Apr 9.

PMID:
29649424
4.

Sight-threatening complications of cosmetic iris implants.

Kerr NM, Kong YXG, Skalicky SE, Green C.

Clin Exp Ophthalmol. 2018 Nov;46(8):955-956. doi: 10.1111/ceo.13194. Epub 2018 Apr 6. No abstract available.

PMID:
29566302
5.

Ab Interno Gel Implant-associated Bleb-related Infection.

Kerr NM, Wang J, Sandhu A, Harasymowycz PJ, Barton K.

Am J Ophthalmol. 2018 May;189:96-101. doi: 10.1016/j.ajo.2018.02.014. Epub 2018 Feb 28.

PMID:
29499173
6.

Differences in bleb morphology between trabeculectomy and deep sclerectomy.

Kerr NM.

Clin Exp Ophthalmol. 2017 Sep;45(7):675-676. doi: 10.1111/ceo.13037. No abstract available.

PMID:
28991416
7.

Minimally invasive glaucoma surgery as primary stand-alone surgery for glaucoma.

Kerr NM, Wang J, Barton K.

Clin Exp Ophthalmol. 2017 May;45(4):393-400. doi: 10.1111/ceo.12888. Epub 2017 Jan 29. Review.

PMID:
27928879
8.

Selective Laser Trabeculoplasty Reduces Intraocular Pressure Peak in Response to the Water Drinking Test.

Kerr NM, Lew HR, Skalicky SE.

J Glaucoma. 2016 Sep;25(9):727-31. doi: 10.1097/IJG.0000000000000512.

PMID:
27552511
9.

Endophthalmitis associated with Glaucoma Shunt Intraluminal Stent Exposure.

Kwon HJ, Kerr NM, Ruddle JB, Ang GS.

J Curr Glaucoma Pract. 2016 Jan-Apr;10(1):36-7. doi: 10.5005/jp-journals-10008-1199. Epub 2016 May 12.

10.

Glaucoma laser and surgical procedure rates in Australia.

Kerr NM, Kumar HK, Crowston JG, Walland MJ.

Br J Ophthalmol. 2016 Dec;100(12):1686-1691. doi: 10.1136/bjophthalmol-2015-307994. Epub 2016 Mar 11.

PMID:
26969712
11.

Anxiety in visual field testing.

Chew SS, Kerr NM, Wong AB, Craig JP, Chou CY, Danesh-Meyer HV.

Br J Ophthalmol. 2016 Aug;100(8):1128-33. doi: 10.1136/bjophthalmol-2015-307110. Epub 2015 Nov 25.

PMID:
26608027
12.

Effect of femtosecond laser-assisted cataract surgery on the corneal endothelium.

Abell RG, Kerr NM, Howie AR, Mustaffa Kamal MA, Allen PL, Vote BJ.

J Cataract Refract Surg. 2014 Nov;40(11):1777-83. doi: 10.1016/j.jcrs.2014.05.031. Epub 2014 Sep 10. Erratum in: J Cataract Refract Surg. 2015 May;41(5):1128.

PMID:
25217072
13.

Bilateral nanophthalmic uveal effusion syndrome: clinical presentation and surgical management.

Abell RG, Kerr NM, Vote BJ.

Retin Cases Brief Rep. 2013 Fall;7(4):386-90. doi: 10.1097/ICB.0b013e318297f6c1.

PMID:
25383821
14.

Toward zero effective phacoemulsification time using femtosecond laser pretreatment.

Abell RG, Kerr NM, Vote BJ.

Ophthalmology. 2013 May;120(5):942-8. doi: 10.1016/j.ophtha.2012.11.045. Epub 2013 Mar 7.

PMID:
23465860
15.

Intraocular pressure during femtosecond laser pretreatment of cataract.

Kerr NM, Abell RG, Vote BJ, Toh T'.

J Cataract Refract Surg. 2013 Mar;39(3):339-42. doi: 10.1016/j.jcrs.2012.12.008. Epub 2013 Jan 9.

PMID:
23312148
16.

Femtosecond laser-assisted cataract surgery compared with conventional cataract surgery.

Abell RG, Kerr NM, Vote BJ.

Clin Exp Ophthalmol. 2013 Jul;41(5):455-62. doi: 10.1111/ceo.12025. Epub 2012 Dec 10.

PMID:
23078347
17.

Intravitreal injections: is there benefit for a theatre setting?

Abell RG, Kerr NM, Allen P, Vote BJ.

Br J Ophthalmol. 2012 Dec;96(12):1474-8. doi: 10.1136/bjophthalmol-2012-302030. Epub 2012 Sep 27.

PMID:
23018424
18.

Patient satisfaction with topical ocular hypotensives.

Kerr NM, Patel HY, Chew SS, Ali NQ, Eady EK, Danesh-Meyer HV.

Clin Exp Ophthalmol. 2013 Jan-Feb;41(1):27-35. doi: 10.1111/j.1442-9071.2012.02823.x. Epub 2012 Jul 11.

PMID:
22594958
19.

Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia.

Danesh-Meyer HV, Kerr NM, Zhang J, Eady EK, O'Carroll SJ, Nicholson LF, Johnson CS, Green CR.

Brain. 2012 Feb;135(Pt 2):506-20. doi: 10.1093/brain/awr338.

PMID:
22345088
20.

High pressure-induced retinal ischaemia reperfusion causes upregulation of gap junction protein connexin43 prior to retinal ganglion cell loss.

Kerr NM, Johnson CS, Zhang J, Eady EK, Green CR, Danesh-Meyer HV.

Exp Neurol. 2012 Mar;234(1):144-52. doi: 10.1016/j.expneurol.2011.12.027. Epub 2011 Dec 27.

PMID:
22226601

Supplemental Content

Support Center